KEY FEATURES
| Full Name | Renin |
|---|---|
| Synonym | REN |
| Assay Type | Sandwich |
| Reactivity | Monkey |
| Range | 31.25-2000pg/mL |
| Sensitivity | 18.75pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Monkey REN in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Monkey REN. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Monkey REN and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Monkey REN, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Monkey REN. You can calculate the concentration of Monkey REN in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Monkey REN ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 109.45 | 314.2 | 776.02 | 107.72 | 340.75 | 725.93 |
| Standard deviation | 6.77 | 16.24 | 42.22 | 7 | 19.83 | 34.77 |
| CV(%) | 6.19 | 5.17 | 5.44 | 6.5 | 5.82 | 4.79 |
RECOVERY
The recovery of Monkey REN spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 85-98 | 90 |
| EDTA plasma (n=8) | 91-108 | 98 |
| Cell culture media (n=8) | 85-97 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Monkey REN in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with BCR ELISA Kits
| ABL1 ELISA Kit | publications with BCR and ABL1 |
| CRKL ELISA Kit | publications with BCR and CRKL |
| GRB2 ELISA Kit | publications with BCR and GRB2 |
| CBL ELISA Kit | publications with BCR and CBL |
| PIK3CA ELISA Kit | publications with BCR and PIK3CA |
| FES ELISA Kit | publications with BCR and FES |
| VAV2 ELISA Kit | publications with BCR and VAV2 |
| SOS1 ELISA Kit | publications with BCR and SOS1 |
| ARHGDIA ELISA Kit | publications with BCR and ARHGDIA |
| PIK3CG ELISA Kit | publications with BCR and PIK3CG |
Pathways associated with BCR ELISA Kit
| Chronic Myeloid Leukemia Pathway | Chronic Myeloid Leukemia Pathway |
| Disease Pathway | Disease Pathway |
| Pathways In Cancer | Pathways In Cancer |
| Regulation Of RAC1 Activity Pathway | Regulation Of RAC1 Activity Pathway |
| Regulation Of RhoA Activity Pathway | Regulation Of RhoA Activity Pathway |
| Rho GTPase Cycle Pathway | Rho GTPase Cycle Pathway |
| Signal Transduction Pathway | Signal Transduction Pathway |
| Signaling By FGFR In Disease Pathway | Signaling By FGFR In Disease Pathway |
| Signaling By FGFR Mutants Pathway | Signaling By FGFR Mutants Pathway |
Diseases associated with BCR ELISA Kit
| Leukemia | publications with BCR and Leukemia |
| Myeloproliferative Disorders | publications with BCR and Myeloproliferative Disorders |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | publications with BCR and Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
| Leukemia, Myeloid, Acute | publications with BCR and Leukemia, Myeloid, Acute |
| Blast Crisis | publications with BCR and Blast Crisis |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | publications with BCR and Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| Breast Neoplasms | publications with BCR and Breast Neoplasms |
| Neoplasms, Experimental | publications with BCR and Neoplasms, Experimental |
| Nervous System Diseases | publications with BCR and Nervous System Diseases |
| Anemia | publications with BCR and Anemia |
Organs/Tissues associated with BCR ELISA Kit
| Blood | publications with BCR and Blood |
| Bone | publications with BCR and Bone |
| Bone Marrow | publications with BCR and Bone Marrow |
| Spleen | publications with BCR and Spleen |
| Lymph Node | publications with BCR and Lymph Node |
| Liver | publications with BCR and Liver |
| Prostate | publications with BCR and Prostate |
| Lymph | publications with BCR and Lymph |
| Lung | publications with BCR and Lung |
| Skin | publications with BCR and Skin |